buy any report dpiresearch reports 1

United States Influenza Vaccine Market Outlook By 2025 | Key Players – Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus

DPI Research reports titled “United States Influenza Vaccine Market” and forecast to 2022 gives a detailed analysis of the market with key company profiles. The Vaccine market is evaluated based on two segments i.e., by type and application and covers essential statistics and details for current and future market scenarios. The report actively includes informative aspects relating to product developments, launches, and trends, to assist market players, shareholders, and investors in strategic decision making.

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.

Major and Promising Vaccine covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Key Companies Covered in the Report are as follows

1. Sanofi Pasteur
2. GlaxoSmithKline(GSK)
3. Seqirus
4. AstraZenecca
5. Protein Sciences Corporation
6. Novavax
7. Daiichi–Sankyo
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
10. VaxInnate

Table of Contents

1. Executive Summary

2. United States Influenza Vaccine Market & Forecast

3. United States Number of Persons Vaccinated with Influenza Vaccine
3.1 Number of Children Vaccinated
3.2 Number of Adults Vaccinated

4. United States Influenza Vaccine Market Drivers and Barriers
4.1 Market Drivers
4.2 Market Barriers

5. United States Influenza Vaccine Production & Distribution
5.1 Vaccine Choices Remain Available for Patients, Providers
5.2 Influenza Vaccine Price Trends
5.2.1 Pediatric Influenza Vaccine Price Trends
5.2.2 Adult Influenza Vaccine Price Trends
5.3 Influenza Vaccine Production, Supply, and Allocation
5.4 Influenza Vaccine Distribution & Demand
5.5 Influenza Vaccine Effectiveness
5.6 Managing Influenza with Diagnostic Resources
5.7 Distribution Method of Influenza Vaccination

6. United States Influenza Vaccine Market – Regulatory Landscape

7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations
7.1 Merger & Acquisitions
7.2 Collaboration Deal
7.3 Licensing, Exclusive & Distribution Agreement Deal
7.3.1 Licensing Agreement
7.3.2 Exclusive Agreement
7.3.3 Distribution Agreement

8. Influenza Vaccine – Pipeline Assessment
8.1 Promising Vaccine in Clinical Development
8.2 Promising Vaccine in Early–Stage Development

9. Influenza Vaccine – Clinical Trials Assessment by Phase and Trial Status
9.1 Year 2016
9.2 Year 2015
9.3 Year 2014
9.4 Year 2013

10. Key Companies Analysis
10.1 Sanofi Pasteur
10.1.1 Business Overview
10.1.2 Sanofi Pasteur – Influenza Vaccine Outlook Fluzone High–Dose Vaccine Fluzone Quadrivalent Vaccine Intradermal (ID) Trivalent Influenza Vaccine Vaxigrip Vaccine
10.1.3 Influenza Vaccine Sales Analysis
10.2 GlaxoSmithKline (GSK)
10.2.1 GlaxoSmithKline(GSK) – Influenza Vaccine Outlook Fluarix Quadrivalent Flulaval Quadrivalent
10.2.2 Influenza Vaccine Sales Analysis & Forecast
10.3 AstraZeneca
10.3.1 Business Overview
10.3.2 AstraZeneca – Influenza Vaccine Outlook Fluenz Tetra/FluMist Quadrivalent
10.3.3 Influenza Vaccine Sales Analysis
10.4 Protein Sciences Corporation
10.4.1 Business Overview
10.4.2 Protein Sciences Corporation – Influenza Vaccine Outlook Flublok
10.5 Seqirus (CSL Limited)
10.5.1 Business Overview
10.5.2 Seqirus – Influenza Vaccine Outlook Flucelvax Quadrivalent Afluria Quadrivalent Agrippal Fluad Fluvirin Fluvax

The report is readily available and can be dispatched immediately after payment confirmation.

More Information @

Would like to place an order or any question, please feel free to contact at

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Maria Rai
Head of Business Development
DPI Research | Web:
Direct Line: +91-766-764-8693

Spread the love

Leave a Reply

Your email address will not be published.